CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
CellControldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02923271
NCT02923271N/ACompleted
CompareCT.gov

Promoting Intrafamily Accountability for Reducing Cellphone Use While Driving in Adults and Their Teen Children

Children's Hospital of Philadelphia·interventional·Posted Oct 4, 2016·Updated Aug 20, 2019

In Brief

A clinical study evaluating CellControl for Teen Drivers and Motor Vehicle Accidents. Completed, enrolled 34 participants across 2 sites.

Detailed Summary

Research participants and their parents will be recruited to take part in a randomized control trial. Participants' and their parents' cellphone use will be observed during an initial baseline period. Participants and their parents will then be randomly assigned to one of two conditions: opt-out blocking with parental notification, opt-out blocking with bidirectional notification.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTeen Drivers, Motor Vehicle Accidents
CountriesUnited States
CollaboratorsUniversity of Pennsylvania

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 4, 2016
Enrollment StartDec 7, 2016
Primary CompletionSep 13, 2017
Study CompletionNov 16, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.7 years ago

Interventions

CellControldevice

Technology that blocks incoming and outgoing calls and texts. CellControl Drive ID will monitor all cellphone use while driving (without blocking) for 3 weeks during baseline measurement period. During the intervention period (5 weeks) cellphone use will be monitored and blocking of incoming calls and texts will be active.